Macfarlan Smith, a wholly owned subsidiary of Johnson Matthey plc, is a manufacturer of active pharmaceutical ingredients (APIs) and fine chemicals. It is also a world leader in the production of alkaloid opiates and other controlled drugs.

    The company operates a state-of-the-art plant to the highest level of cGMP, and offers a comprehensive contract manufacturing facility ranging from the development of novel synthetic processes, through labscale production to the provision of multi-tonne custom synthesis, including the toll extraction of active principles from natural processes.

    A high level of product containment is maintained throughout the production cycle and all products are isolated in controlled environment finishing suites.